Brunt, Elizabeth M.
Wong, Vincent W.-S.
Nobili, Valerio
Day, Christopher P.
Sookoian, Silvia
Maher, Jacquelyn J.
Bugianesi, Elisabetta
Sirlin, Claude B.
Neuschwander-Tetri, Brent A.
Rinella, Mary E.
Article History
First Online: 17 December 2015
Competing interests
: E.M.B. has received consulting fees from Eli Lilly and acted as a paid study pathologist for Rottapharm. C.B.S. has received research grants from GE Healthcare and Siemens. V.W.-S.W. is or has been an advisory board member for Gilead and Janssen, a consultant for AbbVie, Merck and NovoMedica, and has received lecture fees from AbbVie, Echosens and Gilead. B.A.N.-T. has received consulting fees from Nimbus Therapeutics, Bristol-Myers Squibb, Janssen, Conatus, Scholar Rock, Novartis, Galmed, Zafgen and Pfizer. All other authors declare no competing interests.